Tag Archives: Chronic

FDA Approves Epclusa (sofosbuvir/velpatasvir) for Children Ages 6 and Older or Weighing at Least 17 kg with Chronic Hepatitis C Infection

Print this page FOSTER CITY, Calif.–(BUSINESS WIRE)– Gilead Sciences, Inc. (NASDAQ: GILD) announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Epclusa® (sofosbuvir 400mg/velpatasvir 100mg; sofosbuvir 200mg/velpatasvir 50 mg) for the treatment of people with chronic hepatitis C infection (HCV) as young as 6 years of age or weighing at… Read More »

Is chronic wasting disease in deer dangerous for humans?

‘Zombie deer’ destined for Nevada invasion Officials are trying to prevent ‘zombie deer’ from entering the state of Nevada. ‘Zombie deer’ are creatures that have contracted chronic wasting disease, a highly contagious and often deadly affliction that has ravaged the deer population in an estimated 24 states and two Canadian provinces. Hi Dr. Manny, What… Read More »

FDA Approves Calquence for Adults with Chronic Lymphocytic Leukemia

Print this page 21 November 2019 — AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved Calquence (acalabrutinib) for adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).1 The US approval was granted under the FDA’s Real-Time Oncology Review and newly established Project Orbis programmes. The approval is based on positive… Read More »

Reviewing Interventional Treatments for Chronic Headache – Medical Bag

When chronic headaches and facial pain are complicated by comorbidities, polypharmacy, intolerance, or refractory pain, some clinicians are turning to interventional modalities to ease headache pain.1 Patients who cannot get relief with acute treatment were found to be 2 to 3 times more likely to transition to chronic migraine.2 Interventions to treat the most common… Read More »